523 related articles for article (PubMed ID: 19584706)
21. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic effects of recombinant interferon-gamma on lymphocytes cultures from patients with non-small cell lung cancer.
Baka S; Ekonomopoulou MT; Kosmidis C; Efthimiadis C; Iakovidou-Kritsi Z
Cancer Genet Cytogenet; 2009 Aug; 193(1):38-43. PubMed ID: 19602462
[TBL] [Abstract][Full Text] [Related]
23. Genotoxicity testing of fluconazole in vivo and in vitro.
Yüzbaşioğlu D; Unal F; Yilmaz S; Aksoy H; Celik M
Mutat Res; 2008 Jan; 649(1-2):155-60. PubMed ID: 18053758
[TBL] [Abstract][Full Text] [Related]
24. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
Terlikowski S; Sulkowska M; Nowak HF
J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
[TBL] [Abstract][Full Text] [Related]
25. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Kelner MJ; McMorris TC; Rojas RJ; Trani NA; Estes L
Cancer Chemother Pharmacol; 2002 May; 49(5):412-8. PubMed ID: 11976836
[TBL] [Abstract][Full Text] [Related]
26. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
Socaciu C; Bara A; Silvestru C; Haiduc I
In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
[TBL] [Abstract][Full Text] [Related]
27. Chalone-like inhibition of Ehrlich ascites cell proliferation in vitro by an ultrafiltrate obtained from the ascitic fluid.
Lehmann W; Graetz H; Schütt M; Langen P
Acta Biol Med Ger; 1977; 36(7-8):K 43-52. PubMed ID: 148196
[TBL] [Abstract][Full Text] [Related]
28. Genotoxicity and cytotoxicity of cisplatin treatment combined with anaesthetics on EAT cells in vivo.
Brozovic G; Orsolic N; Knezevic F; Horvat Knezevic A; Benkovic V; Sakic K; Hrgovic Z; Bendelja K; Fassbender WJ
Onkologie; 2009 Jun; 32(6):337-43. PubMed ID: 19521121
[TBL] [Abstract][Full Text] [Related]
29. [Affect of As(2)O(3) on the sister chromatid exchanges in human blood lymphocytes].
Chen L; Liang Y; Jiang S
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):363-5. PubMed ID: 11877099
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of cytogenetic effects by erythropoietin in human lymphocytes in vitro and P388 ascites tumor cells in vivo treated with irinotecan (CPT-11).
Digkas E; Kareli D; Chrisafi S; Passadaki T; Mantadakis E; Hatzimichail A; Vargemezis V; Lialiaris T
Food Chem Toxicol; 2010 Jan; 48(1):242-9. PubMed ID: 19819285
[TBL] [Abstract][Full Text] [Related]
32. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
Singh V; Singh SM
Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
[TBL] [Abstract][Full Text] [Related]
33. Synergistic induction of cytogenetic damage by the homo-aza-steroidal ester of p-bis(2-chloroethyl)aminophenylacetic acid in combination with caffeine in human lymphocytes in vitro and in Ehrlich ascites tumour cells in vivo.
Petrou C; Mourelatos D; Dozi-Vassiliades J; Catsoulacos P
Mutat Res; 1990 Feb; 243(2):109-13. PubMed ID: 2304481
[TBL] [Abstract][Full Text] [Related]
34. Suppression of the formation of sister chromatid exchanges by low concentrations of ginsenoside Rh2 in human blood lymphocytes.
Zhu JH; Takeshita T; Kitagawa I; Morimoto K
Cancer Res; 1995 Mar; 55(6):1221-3. PubMed ID: 7882311
[TBL] [Abstract][Full Text] [Related]
35. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds.
Koch B; Baul TS; Chatterjee A
J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440
[TBL] [Abstract][Full Text] [Related]
36. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice.
Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H
Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970
[TBL] [Abstract][Full Text] [Related]
37. In vivo assessment of toxicity and pharmacokinetics of methylglyoxal. Augmentation of the curative effect of methylglyoxal on cancer-bearing mice by ascorbic acid and creatine.
Ghosh M; Talukdar D; Ghosh S; Bhattacharyya N; Ray M; Ray S
Toxicol Appl Pharmacol; 2006 Apr; 212(1):45-58. PubMed ID: 16112157
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of 5- and 6-N-heterocyclic methylenebisphosphonate derivatives and evaluation of their cytogenetic activity in normal human lymphocyte cultures.
Abdou WM; Kamel AA; Khidre RE; Geronikaki A; Ekonomopoulou MT
Chem Biol Drug Des; 2012 May; 79(5):719-30. PubMed ID: 22243546
[TBL] [Abstract][Full Text] [Related]
39. Cytostatic and cytotoxic response of Ehrlich ascites tumor cells in vivo on chronic treatment with cytarabine, bleomycin, and peplomycin.
Stoehr M; Friedel G; Engel P; Goerttler K; Futterman G
Arzneimittelforschung; 1984; 34(4):451-4. PubMed ID: 6204650
[TBL] [Abstract][Full Text] [Related]
40. Paullinia cupana Mart. var. sorbilis, guarana, increases survival of Ehrlich ascites carcinoma (EAC) bearing mice by decreasing cyclin-D1 expression and inducing a G0/G1 cell cycle arrest in EAC cells.
Fukumasu H; Latorre AO; Zaidan-Dagli ML
Phytother Res; 2011 Jan; 25(1):11-6. PubMed ID: 20564499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
